El-Gamal, R., Elfarrash, S., EL-Nablaway, M., Salem, A. A., Zaraei, S., Anbar, H. S., . . . El-Gamal, M. I. (2023). Anti-proliferative activity of RIHMS-Qi-23 against MCF-7 breast cancer cell line is through inhibition of cell proliferation and senescence but not inhibition of targeted kinases. BMC Cancer, 23(1), 1. https://doi.org/10.1186/s12885-023-11547-1
Chicago Style (17th ed.) CitationEl-Gamal, Randa, Sara Elfarrash, Mohammad EL-Nablaway, Asmaa Ahmed Salem, Seyed-Omar Zaraei, Hanan S. Anbar, Ashraf Shoma, and Mohammed I. El-Gamal. "Anti-proliferative Activity of RIHMS-Qi-23 Against MCF-7 Breast Cancer Cell Line Is Through Inhibition of Cell Proliferation and Senescence but Not Inhibition of Targeted Kinases." BMC Cancer 23, no. 1 (2023): 1. https://doi.org/10.1186/s12885-023-11547-1.
MLA (9th ed.) CitationEl-Gamal, Randa, et al. "Anti-proliferative Activity of RIHMS-Qi-23 Against MCF-7 Breast Cancer Cell Line Is Through Inhibition of Cell Proliferation and Senescence but Not Inhibition of Targeted Kinases." BMC Cancer, vol. 23, no. 1, 2023, p. 1, https://doi.org/10.1186/s12885-023-11547-1.